Literature DB >> 32290726

Protease propeptide structures, mechanisms of activation, and functions.

Lise Boon1, Estefania Ugarte-Berzal1, Jennifer Vandooren1, Ghislain Opdenakker1.   

Abstract

Proteases are a diverse group of hydrolytic enzymes, ranging from single-domain catalytic molecules to sophisticated multi-functional macromolecules. Human proteases are divided into five mechanistic classes: aspartate, cysteine, metallo, serine and threonine proteases, based on the catalytic mechanism of hydrolysis. As a protective mechanism against uncontrolled proteolysis, proteases are often produced and secreted as inactive precursors, called zymogens, containing inhibitory N-terminal propeptides. Protease propeptide structures vary considerably in length, ranging from dipeptides and propeptides of about 10 amino acids to complex multifunctional prodomains with hundreds of residues. Interestingly, sequence analysis of the different protease domains has demonstrated that propeptide sequences present higher heterogeneity compared with their catalytic domains. Therefore, we suggest that protease inhibition targeting propeptides might be more specific and have less off-target effects than classical inhibitors. The roles of propeptides, besides keeping protease latency, include correct folding of proteases, compartmentalization, liganding, and functional modulation. Changes in the propeptide sequence, thus, have a tremendous impact on the cognate enzymes. Small modifications of the propeptide sequences modulate the activity of the enzymes, which may be useful as a therapeutic strategy. This review provides an overview of known human proteases, with a focus on the role of their propeptides. We review propeptide functions, activation mechanisms, and possible therapeutic applications.

Entities:  

Keywords:  Human; activation; enzymes; latency; propeptides; proteases

Mesh:

Substances:

Year:  2020        PMID: 32290726     DOI: 10.1080/10409238.2020.1742090

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  9 in total

1.  Structure of the Plasmodium falciparum PfSERA5 pseudo-zymogen.

Authors:  Nicholas A Smith; Oliver B Clarke; Mihwa Lee; Anthony N Hodder; Brian J Smith
Journal:  Protein Sci       Date:  2020-10-05       Impact factor: 6.725

2.  Molecular architecture and modifications of full-length myocilin.

Authors:  Mackenzie D Martin; Dustin J E Huard; Ricardo C Guerrero-Ferreira; Ishani M Desai; Brett M Barlow; Raquel L Lieberman
Journal:  Exp Eye Res       Date:  2021-08-13       Impact factor: 3.770

3.  Structure of Human TMPRSS2 in Complex with SARS-CoV-2 Spike Glycoprotein and Implications for Potential Therapeutics.

Authors:  Naveen Vankadari; Vijayasarathy Ketavarapu; Sasikala Mitnala; Ravikanth Vishnubotla; Duvvur Nageshwar Reddy; Debnath Ghosal
Journal:  J Phys Chem Lett       Date:  2022-06-08       Impact factor: 6.888

Review 4.  Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer's Disease.

Authors:  Lidia Ciccone; Jennifer Vandooren; Susanna Nencetti; Elisabetta Orlandini
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-24

5.  Massively parallel, computationally guided design of a proenzyme.

Authors:  Brahm J Yachnin; Laura R Azouz; Ralph E White; Conceição A S A Minetti; David P Remeta; Victor M Tan; Justin M Drake; Sagar D Khare
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-04       Impact factor: 12.779

6.  Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase.

Authors:  Christos S Karamitros; Catrina M Somody; Giulia Agnello; Scott Rowlinson
Journal:  Front Bioeng Biotechnol       Date:  2021-12-17

7.  Calpains in cyanobacteria and the origin of calpains.

Authors:  Dominika Vešelényiová; Lenka Hutárová; Alexandra Lukáčová; Mária Schneiderová; Matej Vesteg; Juraj Krajčovič
Journal:  Sci Rep       Date:  2022-08-16       Impact factor: 4.996

8.  Molecular and in vivo studies of a glutamate-class prolyl-endopeptidase for coeliac disease therapy.

Authors:  Laura Del Amo-Maestro; Soraia R Mendes; Arturo Rodríguez-Banqueri; Laura Garzon-Flores; Marina Girbal; María José Rodríguez-Lagunas; Tibisay Guevara; Àngels Franch; Francisco J Pérez-Cano; Ulrich Eckhard; F Xavier Gomis-Rüth
Journal:  Nat Commun       Date:  2022-08-01       Impact factor: 17.694

9.  Secretion of collagenases by Saccharomyces cerevisiae for collagen degradation.

Authors:  Han Xiao; Xiufang Liu; Yunzi Feng; Lin Zheng; Mouming Zhao; Mingtao Huang
Journal:  Biotechnol Biofuels Bioprod       Date:  2022-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.